Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older

Condition:   Asthma
Interventions:   Drug: Treatment A: Fp MDPI;   Drug: Treatment B: FS MDPI;   Drug: Treatment C Flovent;   Drug: Treatment D:  Advair
Sponsor:   Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified May 2015

View full post on asthma | received in the last 14 days